```json
{
"content": [
{
"type": "paragraph",
"content": "The Angioplasty Balloons ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream clinical application. Value creation begins with component suppliers and technology developers, flows through OEMs and distributors, and culminates in end-user adoption. Regulatory compliance and interoperability with imaging systems act as critical control points, while supply chain efficiency and clinical efficacy determine overall market dynamics."
},
{
"type": "list",
"items": [
{ "text": "Raw material/component suppliers — supply polymers, metals, coatings for balloon production", "level": 1 },
{ "text": "OEMs/Manufacturers — design and produce angioplasty balloons to medical standards", "level": 1 },
{ "text": "Technology providers — develop inflation systems and imaging compatibility solutions", "level": 1 },
{ "text": "Distributors/Channel partners — manage logistics and supply chain to healthcare facilities", "level": 1 },
{ "text": "End users (hospitals, clinics) — perform interventional procedures using the balloons", "level": 1 },
{ "text": "Regulators/standards bodies — oversee compliance with safety and quality regulations", "level": 1 },
{ "text": "Service providers/after-sales — offer maintenance, training, and technical support post-purchase", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Control points reside with regulators governing approvals and technology providers enabling device compatibility. Dependency risks include raw material availability and adherence to evolving safety standards. Switching costs are moderate between distributors but high for specialized manufacturing due to certification requirements. Regional ecosystems vary in regulatory stringency and procurement models, particularly between developed and emerging markets."
}
]
}
```
